Femasys/$FEMY
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Femasys
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Ticker
$FEMY
Sector
Primary listing
Employees
70
Headquarters
Website
Femasys Metrics
BasicAdvanced
$59M
-
-$0.67
-2.54
-
Price and volume
Market cap
$59M
Beta
-2.54
52-week high
$1.76
52-week low
$0.31
Average daily volume
8.4M
Financial strength
Current ratio
1.162
Quick ratio
0.488
Long term debt to equity
25.202
Total debt to equity
184.956
Interest coverage (TTM)
-9.20%
Profitability
EBITDA (TTM)
-17.35
Gross margin (TTM)
63.05%
Net profit margin (TTM)
-960.53%
Operating margin (TTM)
-858.04%
Effective tax rate (TTM)
-0.03%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-69.37%
Return on equity (TTM)
-376.23%
Valuation
Price to revenue (TTM)
14.461
Price to book
10.49
Price to tangible book (TTM)
10.79
Price to free cash flow (TTM)
-1.481
Free cash flow yield (TTM)
-67.50%
Free cash flow per share (TTM)
-0.682
Growth
Revenue change (TTM)
63.53%
Earnings per share change (TTM)
-18.79%
3-year revenue growth (CAGR)
18.90%
3-year earnings per share growth (CAGR)
-9.96%
Femasys News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Femasys stock?
Femasys (FEMY) has a market cap of $59M as of December 01, 2025.
What is the P/E ratio for Femasys stock?
The price to earnings (P/E) ratio for Femasys (FEMY) stock is 0 as of December 01, 2025.
Does Femasys stock pay dividends?
No, Femasys (FEMY) stock does not pay dividends to its shareholders as of December 01, 2025.
When is the next Femasys dividend payment date?
Femasys (FEMY) stock does not pay dividends to its shareholders.
What is the beta indicator for Femasys?
Femasys (FEMY) has a beta rating of -2.54. This means that it has an inverse relation to market volatility.